Industry & Business

AstraZeneca’s blood-thinning drug Brilinta fails clinical trials

 Breaking News
  • Neueda Technologies Establishing a Software Engineering Hub in Athlone Neueda Technologies, a privately-owned IT Training, development and consulting services company headquartered in Belfast, is establishing a Software Engineering Hub in Athlone, Co. Westmeath, employing 200 staff over four years. The project is supported by the Irish Government through IDA Ireland. The company will undertake software development services for global telecommunications and financial services clients at [...]...
  • Progress at Last! – British Irish Chamber Welcomes UK White Paper on Brexit The British Irish Chamber of Commerce has welcomed the publication of the white paper on Brexit by the UK Government but has called for a full agreement on services to be sought.   Commenting after the publication of the white paper, John McGrane, the Director-General of the British Irish Chamber of Commerce, said: “At last we [...]...
  • Fexco to Create 175 New Jobs in Ireland’s South West Irish-international fintech company, Fexco has announced a significant expansion of its operations headquartered in Killorglin, Co Kerry creating 175 new jobs over 3 years. The jobs form part of Fexco’s expansion strategy reinforcing the South West’s position as the driving force of Ireland’s fintech industry. The announcement was made in Killorglin by Julie Sinnamon, CEO of [...]...
  • Reliance on UK Exports Could Lead to High Brexit Cost Increases For Irish Firms Irish-owned firms rely heavily on the UK as the source of intermediate inputs, which are goods used to produce a final product. Over half of the total imports used by Irish-owned firms are sourced in the UK with many importing solely from the UK market. Many Irish-owned companies are therefore highly exposed to cost increases [...]...
  • Center Parcs Serves Up €5.2 Million in Contracts to Irish Food Companies Four of Ireland’s top food companies will benefit from a significant boost to their businesses as Center Parcs announces the awarding of food supplier contracts to its Center Parcs Longford Forest resort – due to open in summer 2019 – worth a combined total of €5.2 million. Center Parcs has awarded the following food supplier contracts: Dublin [...]...

AstraZeneca’s blood-thinning drug Brilinta fails clinical trials

March 23
09:48 2016

clinic-doctor-health-hospital-mediumAstraZeneca Plc has said today that its blood-thinning drug Brilinta failed to help stroke patients as hoped in a major clinical trial. Brilinta didn’t outperform aspirin in the three-month long test on patients with stroke, dealing a blow to a product viewed as an important driver of future sales and profits.

In a clinical trial dubbed Socrates, Brilinta taken twice daily was compared to a once- daily dose of aspirin in patients with two forms of stroke. Those taking the drug had fewer heart attacks, other stroke or death.

While AstraZeneca said “fewer events” were observed in the patients taking Brilinta, the overall trend from the trial did not reach “statistical significance”.

While this latest trial will not affect the current usage of Brilinta, which accounted for 2.5 per cent of AstraZeneca’s total revenues last year, the results will likely come as a blow to the group as it tries to find alternative sources of income to make up for the loss of market exclusivity in the US this year for its best-selling drug Crestor, an anti-cholesterol statin.

Chief Executive Officer Pascal Soriot has identified Brilinta as critical to reaching $45 billion in annual revenue by 2023, a goal set in 2014 as AstraZeneca fended off a takeover attempt by Pfizer Inc. The anti-clotting medicine is sold as a treatment after heart attacks, but AstraZeneca is conducting studies intended to expand the population of patients who can take the pill.

The full results of the trial will be presented at a medical conference on stroke.

About Author



Related Articles

New Subscriber

Subscribe Here


National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories

Upcoming Events

  • No upcoming events
AEC v1.0.4